Interview with Diana Valencia, Executive Director, LatAm Clinical Trials
While LatAm originally emerged from the SIPLAS organization, how was it evolved since then to be where it is today? LatAm was born in 2000 as a business unit of…
Address: Av. 9 No. 123-86 / Of. 703 Bogotá D.C. Colombia
Tel: (571) 6203530
Web: http://www.latamtrials.com/
Latam Clinical Trials specializes in conducting superior Phase I-IV clinical trials in Latin America, specifically in the Andean Region, Central America and the Caribbean, offering our three services lines: Conducting and Monitoring Clinical trials, Management of Regulatory Issues, and training.
Latam Clinical Trials has business development offices in the USA and clinical staff located in the Andean Countries of South America and in Central America, giving access to substantial underutilized medical expertise and infrastructure throughout an area that includes Ecuador, Colombia, Peru, Panama and Venezuela.
Latam Clinical Trials’ geographic reach is extended to additional countries in Latin America through partnerships with other local CROs in Mexico, Argentina and Brazil
Regulatory Support and Submission, Patient Recruitment Management, Project Management
While LatAm originally emerged from the SIPLAS organization, how was it evolved since then to be where it is today? LatAm was born in 2000 as a business unit of…
Marisol Sanchez, executive president of ANDI’s Medical Devices Chamber in Colombia, speaks about the opportunities and challenges in the country’s medtech sector, the industry’s strong ethical code, the key role…
Guillermo Gómez, managing director of the Andean region at Siemens Healthineers discusses Colombia’s evolution in terms of access to healthcare and investment in life-saving medical equipment, as well as the…
Eduardo Obraczka, managing director at Merck Colombia, shares his appreciation for the flexibility of the Colombian talent pool, while explaining Merck’s successful strategy that has led to the impressive growth…
Luz Stella Gomez, General Manager for the Colombian medical device distributor Gemedco, talks about the positive impact that INVIMA’s regulations have had on the Colombian health sector, Gemedco’s portfolio evolution…
Adriana Forero, General Manager of GSK Colombia, speaks about their efforts to remain at the forefront of the healthcare industry, while keeping their focus on increasing access, innovation and focus…
Oscar Fernando Otalora Gomez, Executive Director of HB Human Bioscience, discusses the importance of bringing innovation and technology to the Colombian market, while being committed to providing medication at a…
Gianfranco Biliotti, recently appointed General Manager for Alexion Colombia, shares his insights on the particularities of operating in the ultra-rare disease segment, while highlighting the importance of managerial flexibility, the…
Javier Castro of Boehringer Ingelheim (BI) Colombia has been mandated to integrate Sanofi’s animal healthcare business into BI’s operation and prepare the Colombian affiliate for the coming changes in the…
Commission Seven’s Representative to the Chamber, Rafael Romero Piñeros, shares his insights on the dynamics of the Colombian healthcare system. He speaks about the major changes in the healthcare system…
Carlos and Esteban Arteaga, CEO and Line Manager at Medivelius, a company that distributes European dermocosmetic products of the highest quality in a price driven Colombian market, discuss how their…
Sandra Cifuentes, General Manager of Astellas Farma Colombia, one of the most recent entrants in the Colombian market, explains the strategic priorities for establishing a strong position in the country,…
Ana Claudia Alvarez, the recently appointed Country Manager for GE Healthcare Colombia, discusses the company’s transition from hardware-based activities to advisory services, the relationship between medical equipment presence and cost…
See our Cookie Privacy Policy Here
